Diabetes Mellitus, Type 2 Clinical Trial
— APETEXOfficial title:
Efficacy of a Nutritional Education Strategy and Role of Physical Exercise on the Regulation of Appetite and Body Composition Through the Profile of Exosomes in Type 2 Diabetics (The APETEX Project)
We hypothesize that the combination of a nutritional education intervention with a physical exercise program improves appetite regulation mediated by exosomes in people with Type 2 Diabetes Mellitus (T2DM), leading to better glycaemia/insulinaemia levels, reduction of body fat mass and quality of life. The project is a randomized controlled clinical trial in 120 participants with T2DM and obesity, which aims to determine the efficacy of a nutritional education program and the role of physical exercise type on health related variables. The participants will be of both sexes with age between 40 and 55 years, belonging to the Province of Cádiz. The design has two 12-week interventions; the main factor has 2 levels: participants who receive the nutritional education (EDU) and controls (CG); the second factor has 3 levels: high-intensity interval training (HIIT), moderate intensity continuous training (MICT), and controls (INACT). Therefore, participants will be randomized into 6 groups (n=20), adjusted by gender (≈50% in each group): EDU+HIIT, EDU+MICT, EDU+INACT, CG+HIIT, CG+MICT, CG+INACT. The outcome variables, which will be measured before and after the intervention, will include: dietary intake assessment, physical activity assessment, quality of life, blood samples, emotional reactivity to food images, blood pressure, appetite assessment, body composition and fluids, basal metabolism, maximal fat oxidation test and cardiorespiratory fitness.
| Status | Recruiting |
| Enrollment | 120 |
| Est. completion date | August 31, 2024 |
| Est. primary completion date | September 1, 2023 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 40 Years to 55 Years |
| Eligibility | Inclusion Criteria: - Nonsmoking - Non-alcoholic (<3 standard drinks per day) - Body mass index >25 kg/m maintaining the habitual dietary patterns without a body mass reduction higher than 2% during the last 6 months - Not being insulin dependent - Absence of injury, disease or disability or other known medical condition which could affect the ability to successfully participate in physical exercise tests - Absence of cardiovascular disease (angina, peripheral or cerebro-vascular disease, etc.). - Absence of neurologic and psychiatric diseases. - Absence of respiratory diseases (pulmonary hypertension, COPD, etc.). - Absence of other metabolic diseases (hyper/hypo parathyroidism, hyper/hypothyroidism, Cushing's disease, Type 1 diabetes, etc.) - Absence of active inflammatory bowel disease - Absence of kidney disease - Absence of tumours - Absence of coagulation dysfunction - Not under treatment with medications k known to affect glucose metabolism, recent steroid treatment (within 6 months), or hormone replacement therapy - Be able to understand a communication in Spanish or English. Exclusion Criteria: - They do not attend more than 2 or 4 consecutive sessions of nutritional counselling or physical training respectively. - The lose more than 4 or 6 sessions in total of nutritional counselling or physical training respectively. |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Science of Education Faculty | Puerto Real | Cadiz |
| Lead Sponsor | Collaborator |
|---|---|
| University of Cadiz | Ministerio de Ciencia e Innovación, Spain |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Assessed changes from Insulin resistance | Glucose and insulin concentrations will be assessed from blood samples in a fasted state of at least 8 hours. They will be determined using the ELISA technique. The HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) insulin sensitivity index will be calculated. | 12 weeks | |
| Primary | Assessed changes from Exosomes | From a blood sample in a fasted state of at least 8 hours. Exosomes will be isolated from plasma using an exoEasy Maxi kit (QIAGEN GmbH) according to the manufacturer's protocol. The quality and quantity of eluted vesicles will be assessed by biochemical analysis for identifying nucleic acids, proteins, lipids, cytokines, transcription factor receptors, and other bioactive substances. | 12 weeks | |
| Primary | Assessed changes from total RNA | Total RNA content will be assessed in a blood sample in a fasted state of at least 8 hours. RNA extraction will be performed from the EX using the Qiagen miRNeasy kit (Qiagen, Hilden) according to the manufacturer's instructions. RNA isolation will be performed on RNeasy MinElute UCP columns according to the manufacturer's recommendations. For quantification and identification of total RNA. | 12 weeks | |
| Primary | Assessed changes from Appetite hormones | From a blood sample in a fasted state of at least 8 hours the appetite-regulating hormones will be assessed. Determined by means of the ELISA technique, including Gastric Inhibitory Polypeptide, Glucagon-like peptide 1, Cholecystokinin , AGRP and Neuropeptide Y. The concentration of hormones will be assessed. | 12 weeks | |
| Primary | Assesed changes from task of emotional reactivity to food images | Task of emotional reactivity to food images will be measured a high-density EEG system (Electrical Geodesics Inc) will be used, which will use 128-channel caps (HydroCel Sensor Net System, EGI, Inc, Eugene OR) with ultra-fast placement, and will be recorded brain activity in a state of rest and during the performance of a cognitive task of visual and attentional type. The images will be presented on a 15 '' monitor and will be divided into three blocks between which the participants can have a break. The stimuli will be extracted from the International Affective Picture System battery (Lang et al., 2008). Images will include over 200 images of foods with high calorie content (eg, cake, potato chips, roast beef and chocolate, etc.), or low calorie content (vegetables, fruit, etc.) They will also include non-food images associated with the animal category or inanimate objects. | 12 weeks | |
| Primary | Assesed changes from Appetite assessment. | Since appetite feeling modulate nutritional behaviour, the evaluation of appetite among the intervention groups can improve the quality of the study from a comprehensive perspective. After a period of 8-10 hours of fasting, an analogue visual scale (AVS) will be completed in order to measure the appetite felt by the participant in the morning. | 12 weeks | |
| Primary | Assessed changes from Body composition: Fatmass and Fat-free mass. | Body composition will be estimated using a multifrequency bioimpedance of 8 electrodes previously validated (TANITAMC780MA). The calculation of impedance can estimate the fat mass and fat-free mass in kilograms. The patients will wear light clothing and will assume a posture in accordance with the manufacturers' instructions. Other previous considerations will be followed 24 hours before the measure: (i) to refrain from vigorous exercise, (ii) to take alcoholic drinks, (iii) to take energy drinks, and (iv) to be in a fasting state for at least 8 hours. Hydration status will be controlled through a urine color scale from clear to dark during the 7 days before assessment for adjusting variables. | 12 weeks | |
| Secondary | Assessed changes from dietary intake: Frequency of consumption | Dietary intake assessment by trained surveyors in a personal interview, using a Food Frequency Questionnaire (FFQ). The FFQ has been previously validated in Mediterranean population of Spain, and provides qualitative frequency of consumption over the last year. In addition, a semi-quantitative analysis of total energy, macro and micro nutrients will be performed. The results will be analysed through the DIAL® software for Windows, version 3.7.1.0, estimating the average of total energy in kilocalories, macro, and micro nutrients in grams for each participant. | 12 weeks | |
| Secondary | Assessed changes from dietary intakes: 24 hours dietary recalls | Dietary intake assessment by trained surveyors in a personal interview, using three 24h dietary recalls (24HR). The results will be analysed through the DIAL® software for Windows, version 3.7.1.0, estimating the average of total energy in kcal, macro, and micro nutrients in grams for each participant. | 12 weeks | |
| Secondary | Assessed changes from accelerometry: Physical activity time | Physical activity assessment will be carried out through GT3X+ accelerometers (direct method) at wrist during 7-consecutive days. The data generated by the accelerometers will be analysed by using ActiLife 6.6.2 software (ActiGraph, Florida; USA), using Freedson (1998) cut points for adults and Choi's validation. Moreover, participants will complete the International Physical Activity Questionnaire Short Version (IPAQ-SF) (indirect method) previously validated in Spain. | 12 weeks | |
| Secondary | Assessed changes from physical activity. | Physical activity assessment will be carried out through GT3X+ accelerometers (direct method) at wrist during 7-consecutive days. The data generated by the accelerometers will be analysed by using ActiLife 6.6.2 software (ActiGraph, Florida; USA), using Freedson (1998) cut points for adults and Choi's validation. Moreover, participants will complete the International Physical Activity Questionnaire Short Version (IPAQ-SF) (indirect method) previously validated in Spain. | 12 weeks | |
| Secondary | Assessed changes from physical activity and sedentary time | Physical activity assessment will be estimated by the participant's self-reported International Physical Activity Questionnaire Short Version (IPAQ-SF) previously validated in Spain. The IPAQ-SF calculates the sedentary time, moderate and vigorous activity time in minutes per week. | 12 weeks | |
| Secondary | Assessed changes from resting fat oxidation | Basal Metabolism will be assessed to determine the Resting Fat Oxidation of each participant before and after the 12-week intervention, since its importance as a health indicator and relationship with obesity. Therefore, Oxygen uptake (VO2), carbon dioxide production (VCO2) will be registered at resting conditions on a bed in a supine position during 30 min. Resting indirect calorimetry will be measured using a gas analyser of an open circuit, Jaeger MasterScreen CPX® (CareFusion, San Diego, USA). Heart Rate will be measured continuously over the test with Polar Team 2 (Polar Electro Inc., Lake Success, NY). Resting Fat Oxidation in grams per minute will be calculated by the indirect equation proposed by Frayn. | 12 weeks | |
| Secondary | Assessed changes from maximal fat oxidation | Maximal fat oxidation test (MFO) to determine the maximal fat oxidation during exercise (MFO), a gradual test on cycloergometer (Lode Excalibur, Netherlands) will be performed. The test will begin with a load of 15Watts, increasing 15Watts every 3 minutes until the respiratory quotient reaches a stable value of 1 or higher. Throughout the test a cadence of 80 r.p.m. will be maintained. Calculation in the base of expired gases will be made for the estimation of grams per minute of fat oxidation. | 12 weeks | |
| Secondary | Assessed changes from cardiorespiratory fitness | Maximum VO2 test: To determine the maximal oxygen consumption (VO2max) during exercise in liters per minute, a gradual test on cycloergometer (Lode Excalibur, Netherlands) will be performed. The gas exchange will be measured by Jaeger MasterScreen CPX® (CareFusion, San Diego, USA)The test will be continuing the MFO from the load when the respiratory quotient reaches a stable value of 1 or higher. Once this point is reached, 15W increments will occur every minute until exhaustion is reached, until achieving the VO2max. Throughout the test a cadence of 80 r.p.m. will be maintained. Heart rate will be recorded in beats per minute. | 12 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |